PubMed study 39364857

Author information is not available in this record

Read on PubMed →

Source-reported research findings

AI-extracted — pending human review. These findings retain the studied context and are not pooled treatment estimates.

Single study

Training, detraining and retraining findings

AI-extracted — pending human review
Source-authored record; platform synthesis is not enabled for this record.
Publication status: published.

Reported arm completers: CRT 22; PRT 20.

randomized parallel training sequences. 55 randomized participants. Analysis population: unclear.

That’s the gist — a fine place to stop. This describes the studied groups, not personal suitability.

Understand the result

Reported arm completers: CRT 22; PRT 20.

Source statement 1

Reported arm completers: CRT 22; PRT 20.

Source statement 2

leg press one repetition maximum — PRT versus CRT; postintervention authors-named postintervention window. No detected between-group difference

Source statement 3

leg press one repetition maximum — Within PRT during the named phase; 10-week detraining period in PRT after the first 10-week resistance-training period. Decrease within the stated arm and phase. Source reported p < 0.05 for the outcome bundle (leg press one repetition maximum, biceps curl one repetition maximum, vastus lateralis muscle cross-sectional area, biceps brachii muscle cross-sectional area, countermovement jump height)

Source statement 4

biceps curl one repetition maximum — PRT versus CRT; postintervention authors-named postintervention window. No detected between-group difference

Source statement 5

biceps curl one repetition maximum — Within PRT during the named phase; 10-week detraining period in PRT after the first 10-week resistance-training period. Decrease within the stated arm and phase. Source reported p < 0.05 for the outcome bundle (leg press one repetition maximum, biceps curl one repetition maximum, vastus lateralis muscle cross-sectional area, biceps brachii muscle cross-sectional area, countermovement jump height)

Source statement 6

vastus lateralis muscle cross-sectional area — PRT versus CRT; postintervention authors-named postintervention window. No detected between-group difference

Source statement 7

vastus lateralis muscle cross-sectional area — Within PRT during the named phase; 10-week detraining period in PRT after the first 10-week resistance-training period. Decrease within the stated arm and phase. Source reported p < 0.05 for the outcome bundle (leg press one repetition maximum, biceps curl one repetition maximum, vastus lateralis muscle cross-sectional area, biceps brachii muscle cross-sectional area, countermovement jump height)

Source statement 8

biceps brachii muscle cross-sectional area — PRT versus CRT; postintervention authors-named postintervention window. No detected between-group difference

Source statement 9

biceps brachii muscle cross-sectional area — Within PRT during the named phase; 10-week detraining period in PRT after the first 10-week resistance-training period. Decrease within the stated arm and phase. Source reported p < 0.05 for the outcome bundle (leg press one repetition maximum, biceps curl one repetition maximum, vastus lateralis muscle cross-sectional area, biceps brachii muscle cross-sectional area, countermovement jump height)

Source statement 10

countermovement jump height — PRT versus CRT; postintervention authors-named postintervention window. No detected between-group difference

Source statement 11

countermovement jump height — Within PRT during the named phase; 10-week detraining period in PRT after the first 10-week resistance-training period. Decrease within the stated arm and phase. Source reported p < 0.05 for the outcome bundle (leg press one repetition maximum, biceps curl one repetition maximum, vastus lateralis muscle cross-sectional area, biceps brachii muscle cross-sectional area, countermovement jump height)

Source statement 12

leg press one repetition maximum — PRT versus CRT; first 5 weeks of retraining in PRT start of retraining after detraining. Compared phases: PRT first 5 weeks of retraining in PRT start of retraining after detraining; CRT Weeks 10-15 of CRT authors-named CRT phase. Greater in the stated experimental group at the compared phases. Source reported p < 0.01 for the outcome bundle (leg press one repetition maximum, vastus lateralis muscle cross-sectional area, biceps brachii muscle cross-sectional area)

Source statement 13

vastus lateralis muscle cross-sectional area — PRT versus CRT; first 5 weeks of retraining in PRT start of retraining after detraining. Compared phases: PRT first 5 weeks of retraining in PRT start of retraining after detraining; CRT Weeks 10-15 of CRT authors-named CRT phase. Greater in the stated experimental group at the compared phases. Source reported p < 0.01 for the outcome bundle (leg press one repetition maximum, vastus lateralis muscle cross-sectional area, biceps brachii muscle cross-sectional area)

Source statement 14

biceps brachii muscle cross-sectional area — PRT versus CRT; first 5 weeks of retraining in PRT start of retraining after detraining. Compared phases: PRT first 5 weeks of retraining in PRT start of retraining after detraining; CRT Weeks 10-15 of CRT authors-named CRT phase. Greater in the stated experimental group at the compared phases. Source reported p < 0.01 for the outcome bundle (leg press one repetition maximum, vastus lateralis muscle cross-sectional area, biceps brachii muscle cross-sectional area)

The full source record is retained in words with its study context and uncertainty. No derived comparison or combined axis is added.

Who & when: randomized parallel training sequences. 55 randomized participants. Analysis population: unclear.
Source: PMID 39364857 · finding version 2

Each record retains its source-reported context and uncertainty.

Same finding version 2; paper version 3. Exact identity, status and limitations remain in this article.

Exact source-reported statements

randomized parallel training sequences. 55 randomized participants. Analysis population: unclear.

Reported arm completers: CRT 22; PRT 20.
leg press one repetition maximum — PRT versus CRT; postintervention authors-named postintervention window. No detected between-group difference
leg press one repetition maximum — Within PRT during the named phase; 10-week detraining period in PRT after the first 10-week resistance-training period. Decrease within the stated arm and phase. Source reported p < 0.05 for the outcome bundle (leg press one repetition maximum, biceps curl one repetition maximum, vastus lateralis muscle cross-sectional area, biceps brachii muscle cross-sectional area, countermovement jump height)
biceps curl one repetition maximum — PRT versus CRT; postintervention authors-named postintervention window. No detected between-group difference
biceps curl one repetition maximum — Within PRT during the named phase; 10-week detraining period in PRT after the first 10-week resistance-training period. Decrease within the stated arm and phase. Source reported p < 0.05 for the outcome bundle (leg press one repetition maximum, biceps curl one repetition maximum, vastus lateralis muscle cross-sectional area, biceps brachii muscle cross-sectional area, countermovement jump height)
vastus lateralis muscle cross-sectional area — PRT versus CRT; postintervention authors-named postintervention window. No detected between-group difference
vastus lateralis muscle cross-sectional area — Within PRT during the named phase; 10-week detraining period in PRT after the first 10-week resistance-training period. Decrease within the stated arm and phase. Source reported p < 0.05 for the outcome bundle (leg press one repetition maximum, biceps curl one repetition maximum, vastus lateralis muscle cross-sectional area, biceps brachii muscle cross-sectional area, countermovement jump height)
biceps brachii muscle cross-sectional area — PRT versus CRT; postintervention authors-named postintervention window. No detected between-group difference
biceps brachii muscle cross-sectional area — Within PRT during the named phase; 10-week detraining period in PRT after the first 10-week resistance-training period. Decrease within the stated arm and phase. Source reported p < 0.05 for the outcome bundle (leg press one repetition maximum, biceps curl one repetition maximum, vastus lateralis muscle cross-sectional area, biceps brachii muscle cross-sectional area, countermovement jump height)
countermovement jump height — PRT versus CRT; postintervention authors-named postintervention window. No detected between-group difference
countermovement jump height — Within PRT during the named phase; 10-week detraining period in PRT after the first 10-week resistance-training period. Decrease within the stated arm and phase. Source reported p < 0.05 for the outcome bundle (leg press one repetition maximum, biceps curl one repetition maximum, vastus lateralis muscle cross-sectional area, biceps brachii muscle cross-sectional area, countermovement jump height)
leg press one repetition maximum — PRT versus CRT; first 5 weeks of retraining in PRT start of retraining after detraining. Compared phases: PRT first 5 weeks of retraining in PRT start of retraining after detraining; CRT Weeks 10-15 of CRT authors-named CRT phase. Greater in the stated experimental group at the compared phases. Source reported p < 0.01 for the outcome bundle (leg press one repetition maximum, vastus lateralis muscle cross-sectional area, biceps brachii muscle cross-sectional area)
vastus lateralis muscle cross-sectional area — PRT versus CRT; first 5 weeks of retraining in PRT start of retraining after detraining. Compared phases: PRT first 5 weeks of retraining in PRT start of retraining after detraining; CRT Weeks 10-15 of CRT authors-named CRT phase. Greater in the stated experimental group at the compared phases. Source reported p < 0.01 for the outcome bundle (leg press one repetition maximum, vastus lateralis muscle cross-sectional area, biceps brachii muscle cross-sectional area)
biceps brachii muscle cross-sectional area — PRT versus CRT; first 5 weeks of retraining in PRT start of retraining after detraining. Compared phases: PRT first 5 weeks of retraining in PRT start of retraining after detraining; CRT Weeks 10-15 of CRT authors-named CRT phase. Greater in the stated experimental group at the compared phases. Source reported p < 0.01 for the outcome bundle (leg press one repetition maximum, vastus lateralis muscle cross-sectional area, biceps brachii muscle cross-sectional area)

Each record retains its source-reported context and uncertainty. No trial arms or new effect estimates are constructed.

Studied context

The context this result was produced in. It bounds what the result can be applied to.
Authors-reported finding	Reported arm completers: CRT 22; PRT 20.
Authors-reported finding	leg press one repetition maximum — PRT versus CRT; postintervention authors-named postintervention window. No detected between-group difference
Authors-reported finding	leg press one repetition maximum — Within PRT during the named phase; 10-week detraining period in PRT after the first 10-week resistance-training period. Decrease within the stated arm and phase. Source reported p < 0.05 for the outcome bundle (leg press one repetition maximum, biceps curl one repetition maximum, vastus lateralis muscle cross-sectional area, biceps brachii muscle cross-sectional area, countermovement jump height)
Authors-reported finding	biceps curl one repetition maximum — PRT versus CRT; postintervention authors-named postintervention window. No detected between-group difference
Authors-reported finding	biceps curl one repetition maximum — Within PRT during the named phase; 10-week detraining period in PRT after the first 10-week resistance-training period. Decrease within the stated arm and phase. Source reported p < 0.05 for the outcome bundle (leg press one repetition maximum, biceps curl one repetition maximum, vastus lateralis muscle cross-sectional area, biceps brachii muscle cross-sectional area, countermovement jump height)
Authors-reported finding	vastus lateralis muscle cross-sectional area — PRT versus CRT; postintervention authors-named postintervention window. No detected between-group difference
Authors-reported finding	vastus lateralis muscle cross-sectional area — Within PRT during the named phase; 10-week detraining period in PRT after the first 10-week resistance-training period. Decrease within the stated arm and phase. Source reported p < 0.05 for the outcome bundle (leg press one repetition maximum, biceps curl one repetition maximum, vastus lateralis muscle cross-sectional area, biceps brachii muscle cross-sectional area, countermovement jump height)
Authors-reported finding	biceps brachii muscle cross-sectional area — PRT versus CRT; postintervention authors-named postintervention window. No detected between-group difference
Authors-reported finding	biceps brachii muscle cross-sectional area — Within PRT during the named phase; 10-week detraining period in PRT after the first 10-week resistance-training period. Decrease within the stated arm and phase. Source reported p < 0.05 for the outcome bundle (leg press one repetition maximum, biceps curl one repetition maximum, vastus lateralis muscle cross-sectional area, biceps brachii muscle cross-sectional area, countermovement jump height)
Authors-reported finding	countermovement jump height — PRT versus CRT; postintervention authors-named postintervention window. No detected between-group difference
Authors-reported finding	countermovement jump height — Within PRT during the named phase; 10-week detraining period in PRT after the first 10-week resistance-training period. Decrease within the stated arm and phase. Source reported p < 0.05 for the outcome bundle (leg press one repetition maximum, biceps curl one repetition maximum, vastus lateralis muscle cross-sectional area, biceps brachii muscle cross-sectional area, countermovement jump height)
Authors-reported finding	leg press one repetition maximum — PRT versus CRT; first 5 weeks of retraining in PRT start of retraining after detraining. Compared phases: PRT first 5 weeks of retraining in PRT start of retraining after detraining; CRT Weeks 10-15 of CRT authors-named CRT phase. Greater in the stated experimental group at the compared phases. Source reported p < 0.01 for the outcome bundle (leg press one repetition maximum, vastus lateralis muscle cross-sectional area, biceps brachii muscle cross-sectional area)
Authors-reported finding	vastus lateralis muscle cross-sectional area — PRT versus CRT; first 5 weeks of retraining in PRT start of retraining after detraining. Compared phases: PRT first 5 weeks of retraining in PRT start of retraining after detraining; CRT Weeks 10-15 of CRT authors-named CRT phase. Greater in the stated experimental group at the compared phases. Source reported p < 0.01 for the outcome bundle (leg press one repetition maximum, vastus lateralis muscle cross-sectional area, biceps brachii muscle cross-sectional area)
Authors-reported finding	biceps brachii muscle cross-sectional area — PRT versus CRT; first 5 weeks of retraining in PRT start of retraining after detraining. Compared phases: PRT first 5 weeks of retraining in PRT start of retraining after detraining; CRT Weeks 10-15 of CRT authors-named CRT phase. Greater in the stated experimental group at the compared phases. Source reported p < 0.01 for the outcome bundle (leg press one repetition maximum, vastus lateralis muscle cross-sectional area, biceps brachii muscle cross-sectional area)

Limitations reported for this finding

Authors-reported study comparisons and phases; no platform pooling.
Completer counts are not randomized arm sizes.
No detected difference is not equivalence or noninferiority.
No numerical effect estimate or cross-phase contrast is computed.
Threshold p values belong to the source-reported outcome bundle, not independently asserted outcome tests.
The abstract reports no between-group differences and similar postintervention adaptations; no endpoint-specific test or equivalence is inferred.
Completer counts are not randomized arm sizes.
No detected difference is not equivalence or noninferiority.
No numerical effect estimate or cross-phase contrast is computed.
Threshold p values belong to the source-reported outcome bundle, not independently asserted outcome tests.
The abstract reports no between-group differences and similar postintervention adaptations; no endpoint-specific test or equivalence is inferred.
Within-arm change during detraining; not a randomized between-group effect.
Completer counts are not randomized arm sizes.
No detected difference is not equivalence or noninferiority.
No numerical effect estimate or cross-phase contrast is computed.
Threshold p values belong to the source-reported outcome bundle, not independently asserted outcome tests.
The abstract reports no between-group differences and similar postintervention adaptations; no endpoint-specific test or equivalence is inferred.
Completer counts are not randomized arm sizes.
No detected difference is not equivalence or noninferiority.
No numerical effect estimate or cross-phase contrast is computed.
Threshold p values belong to the source-reported outcome bundle, not independently asserted outcome tests.
The abstract reports no between-group differences and similar postintervention adaptations; no endpoint-specific test or equivalence is inferred.
Within-arm change during detraining; not a randomized between-group effect.
Completer counts are not randomized arm sizes.
No detected difference is not equivalence or noninferiority.
No numerical effect estimate or cross-phase contrast is computed.
Threshold p values belong to the source-reported outcome bundle, not independently asserted outcome tests.
The abstract reports no between-group differences and similar postintervention adaptations; no endpoint-specific test or equivalence is inferred.
Completer counts are not randomized arm sizes.
No detected difference is not equivalence or noninferiority.
No numerical effect estimate or cross-phase contrast is computed.
Threshold p values belong to the source-reported outcome bundle, not independently asserted outcome tests.
The abstract reports no between-group differences and similar postintervention adaptations; no endpoint-specific test or equivalence is inferred.
Within-arm change during detraining; not a randomized between-group effect.
Completer counts are not randomized arm sizes.
No detected difference is not equivalence or noninferiority.
No numerical effect estimate or cross-phase contrast is computed.
Threshold p values belong to the source-reported outcome bundle, not independently asserted outcome tests.
The abstract reports no between-group differences and similar postintervention adaptations; no endpoint-specific test or equivalence is inferred.
Completer counts are not randomized arm sizes.
No detected difference is not equivalence or noninferiority.
No numerical effect estimate or cross-phase contrast is computed.
Threshold p values belong to the source-reported outcome bundle, not independently asserted outcome tests.
The abstract reports no between-group differences and similar postintervention adaptations; no endpoint-specific test or equivalence is inferred.
Within-arm change during detraining; not a randomized between-group effect.
Completer counts are not randomized arm sizes.
No detected difference is not equivalence or noninferiority.
No numerical effect estimate or cross-phase contrast is computed.
Threshold p values belong to the source-reported outcome bundle, not independently asserted outcome tests.
The abstract reports no between-group differences and similar postintervention adaptations; no endpoint-specific test or equivalence is inferred.
Completer counts are not randomized arm sizes.
No detected difference is not equivalence or noninferiority.
No numerical effect estimate or cross-phase contrast is computed.
Threshold p values belong to the source-reported outcome bundle, not independently asserted outcome tests.
The abstract reports no between-group differences and similar postintervention adaptations; no endpoint-specific test or equivalence is inferred.
Within-arm change during detraining; not a randomized between-group effect.
Completer counts are not randomized arm sizes.
No detected difference is not equivalence or noninferiority.
No numerical effect estimate or cross-phase contrast is computed.
Threshold p values belong to the source-reported outcome bundle, not independently asserted outcome tests.
The abstract reports no between-group differences and similar postintervention adaptations; no endpoint-specific test or equivalence is inferred.
Completer counts are not randomized arm sizes.
No detected difference is not equivalence or noninferiority.
No numerical effect estimate or cross-phase contrast is computed.
Threshold p values belong to the source-reported outcome bundle, not independently asserted outcome tests.
The abstract reports no between-group differences and similar postintervention adaptations; no endpoint-specific test or equivalence is inferred.
Completer counts are not randomized arm sizes.
No detected difference is not equivalence or noninferiority.
No numerical effect estimate or cross-phase contrast is computed.
Threshold p values belong to the source-reported outcome bundle, not independently asserted outcome tests.
The abstract reports no between-group differences and similar postintervention adaptations; no endpoint-specific test or equivalence is inferred.

You can stop here, or inspect the evidence and its original sources.

Reported arm completers: CRT 22; PRT 20.
leg press one repetition maximum — PRT versus CRT; postintervention authors-named postintervention window. No detected between-group difference
leg press one repetition maximum — Within PRT during the named phase; 10-week detraining period in PRT after the first 10-week resistance-training period. Decrease within the stated arm and phase. Source reported p < 0.05 for the outcome bundle (leg press one repetition maximum, biceps curl one repetition maximum, vastus lateralis muscle cross-sectional area, biceps brachii muscle cross-sectional area, countermovement jump height)
biceps curl one repetition maximum — PRT versus CRT; postintervention authors-named postintervention window. No detected between-group difference
biceps curl one repetition maximum — Within PRT during the named phase; 10-week detraining period in PRT after the first 10-week resistance-training period. Decrease within the stated arm and phase. Source reported p < 0.05 for the outcome bundle (leg press one repetition maximum, biceps curl one repetition maximum, vastus lateralis muscle cross-sectional area, biceps brachii muscle cross-sectional area, countermovement jump height)
vastus lateralis muscle cross-sectional area — PRT versus CRT; postintervention authors-named postintervention window. No detected between-group difference
vastus lateralis muscle cross-sectional area — Within PRT during the named phase; 10-week detraining period in PRT after the first 10-week resistance-training period. Decrease within the stated arm and phase. Source reported p < 0.05 for the outcome bundle (leg press one repetition maximum, biceps curl one repetition maximum, vastus lateralis muscle cross-sectional area, biceps brachii muscle cross-sectional area, countermovement jump height)
biceps brachii muscle cross-sectional area — PRT versus CRT; postintervention authors-named postintervention window. No detected between-group difference
biceps brachii muscle cross-sectional area — Within PRT during the named phase; 10-week detraining period in PRT after the first 10-week resistance-training period. Decrease within the stated arm and phase. Source reported p < 0.05 for the outcome bundle (leg press one repetition maximum, biceps curl one repetition maximum, vastus lateralis muscle cross-sectional area, biceps brachii muscle cross-sectional area, countermovement jump height)
countermovement jump height — PRT versus CRT; postintervention authors-named postintervention window. No detected between-group difference
countermovement jump height — Within PRT during the named phase; 10-week detraining period in PRT after the first 10-week resistance-training period. Decrease within the stated arm and phase. Source reported p < 0.05 for the outcome bundle (leg press one repetition maximum, biceps curl one repetition maximum, vastus lateralis muscle cross-sectional area, biceps brachii muscle cross-sectional area, countermovement jump height)
leg press one repetition maximum — PRT versus CRT; first 5 weeks of retraining in PRT start of retraining after detraining. Compared phases: PRT first 5 weeks of retraining in PRT start of retraining after detraining; CRT Weeks 10-15 of CRT authors-named CRT phase. Greater in the stated experimental group at the compared phases. Source reported p < 0.01 for the outcome bundle (leg press one repetition maximum, vastus lateralis muscle cross-sectional area, biceps brachii muscle cross-sectional area)
vastus lateralis muscle cross-sectional area — PRT versus CRT; first 5 weeks of retraining in PRT start of retraining after detraining. Compared phases: PRT first 5 weeks of retraining in PRT start of retraining after detraining; CRT Weeks 10-15 of CRT authors-named CRT phase. Greater in the stated experimental group at the compared phases. Source reported p < 0.01 for the outcome bundle (leg press one repetition maximum, vastus lateralis muscle cross-sectional area, biceps brachii muscle cross-sectional area)
biceps brachii muscle cross-sectional area — PRT versus CRT; first 5 weeks of retraining in PRT start of retraining after detraining. Compared phases: PRT first 5 weeks of retraining in PRT start of retraining after detraining; CRT Weeks 10-15 of CRT authors-named CRT phase. Greater in the stated experimental group at the compared phases. Source reported p < 0.01 for the outcome bundle (leg press one repetition maximum, vastus lateralis muscle cross-sectional area, biceps brachii muscle cross-sectional area)

randomized parallel training sequences. 55 randomized participants. Analysis population: unclear.

Source and extraction detail

Finding revision: finding:examine2025:39364857:1:v2
Finding version: 2
Finding content hash: sha256:6a10c441bd858c17ff9b87c4f4eebc5a0257747201fdd8879be541359878a0f9
Paper version: 3
Paper version content hash: sha256:2bdb127f3ee25c92a6bf1cb57b2a3eaeea3b9dddd26c082f3a18001ee72c7e56
Source content hash: sha256:c02eb924c0ded4a811423052557666500846d5fc5925ccab4f228919d8a868fb
Extraction policy: context164-source-topic-policy:d2c863b8d9f94acf3a7378bfa6e49a23bd72eea4408a689b542d3f7244fd7bfb
Extraction policy hash: sha256:d2c863b8d9f94acf3a7378bfa6e49a23bd72eea4408a689b542d3f7244fd7bfb
Extraction method version: source-reported-records/v1
Field locators: study_comparisons.clause0 → https://eutils.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&id=39364857&rettype=abstract&retmode=text: abstract:624-829; study_comparisons.clause1 → https://eutils.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&id=39364857&rettype=abstract&retmode=text: abstract:830-914; study_comparisons.clause2 → https://eutils.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&id=39364857&rettype=abstract&retmode=text: abstract:915-973; study_comparisons.clause3 → https://eutils.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&id=39364857&rettype=abstract&retmode=text: abstract:1034-1326; study_comparisons.clause4 → https://eutils.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&id=39364857&rettype=abstract&retmode=text: abstract:1327-1451; study_comparisons.clause5 → https://eutils.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&id=39364857&rettype=abstract&retmode=text: abstract:1452-1550; study_comparisons.clause6 → https://eutils.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&id=39364857&rettype=abstract&retmode=text: abstract:1551-1705; study_comparisons.clause7 → https://eutils.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&id=39364857&rettype=abstract&retmode=text: abstract:1706-1866

Source documents

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&id=39364857&rettype=abstract&retmode=text — sha256:c02eb924c0ded4a811423052557666500846d5fc5925ccab4f228919d8a868fb (study_comparisons.clause0 → abstract:624-829; study_comparisons.clause1 → abstract:830-914; study_comparisons.clause2 → abstract:915-973; study_comparisons.clause3 → abstract:1034-1326; study_comparisons.clause4 → abstract:1327-1451; study_comparisons.clause5 → abstract:1452-1550; study_comparisons.clause6 → abstract:1551-1705; study_comparisons.clause7 → abstract:1706-1866; study_comparisons.clause0 → abstract:624-829; study_comparisons.clause1 → abstract:830-914; study_comparisons.clause2 → abstract:915-973; study_comparisons.clause3 → abstract:1034-1326; study_comparisons.clause4 → abstract:1327-1451; study_comparisons.clause5 → abstract:1452-1550; study_comparisons.clause6 → abstract:1551-1705; study_comparisons.clause7 → abstract:1706-1866; sourceTopic.typedRole → Abstract, source context clause 1; sourceTopic.typedRole → Abstract, source context clause 2; sourceTopic.typedRole → Abstract, source context clause 3; sourceTopic.typedRole → Abstract, source context clause 4; sourceTopic.typedRole → Abstract, source context clause 5; sourceTopic.typedRole → Abstract, source context clause 6; sourceTopic.typedRole → Abstract, source context clause 7; sourceTopic.typedRole → Abstract, source context clause 8; study_comparisons.clause0 → abstract:624-829; study_comparisons.clause1 → abstract:830-914; study_comparisons.clause2 → abstract:915-973; study_comparisons.clause3 → abstract:1034-1326; study_comparisons.clause4 → abstract:1327-1451; study_comparisons.clause5 → abstract:1452-1550; study_comparisons.clause6 → abstract:1551-1705; study_comparisons.clause7 → abstract:1706-1866; sourceTopic.typedRole → Abstract, source context clause 1; sourceTopic.typedRole → Abstract, source context clause 2; sourceTopic.typedRole → Abstract, source context clause 3; sourceTopic.typedRole → Abstract, source context clause 4; sourceTopic.typedRole → Abstract, source context clause 5; sourceTopic.typedRole → Abstract, source context clause 6; sourceTopic.typedRole → Abstract, source context clause 7; sourceTopic.typedRole → Abstract, source context clause 8; study_comparisons.clause0 → abstract:624-829; study_comparisons.clause1 → abstract:830-914; study_comparisons.clause2 → abstract:915-973; study_comparisons.clause3 → abstract:1034-1326; study_comparisons.clause4 → abstract:1327-1451; study_comparisons.clause5 → abstract:1452-1550; study_comparisons.clause6 → abstract:1551-1705; study_comparisons.clause7 → abstract:1706-1866; sourceTopic.typedRole → Abstract, source context clause 1; sourceTopic.typedRole → Abstract, source context clause 2; sourceTopic.typedRole → Abstract, source context clause 3; sourceTopic.typedRole → Abstract, source context clause 4; sourceTopic.typedRole → Abstract, source context clause 5; sourceTopic.typedRole → Abstract, source context clause 6; sourceTopic.typedRole → Abstract, source context clause 7; sourceTopic.typedRole → Abstract, source context clause 8; study_comparisons.clause0 → abstract:624-829; study_comparisons.clause1 → abstract:830-914; study_comparisons.clause2 → abstract:915-973; study_comparisons.clause3 → abstract:1034-1326; study_comparisons.clause4 → abstract:1327-1451; study_comparisons.clause5 → abstract:1452-1550; study_comparisons.clause6 → abstract:1551-1705; study_comparisons.clause7 → abstract:1706-1866; sourceTopic.typedRole → Abstract, source context clause 1; sourceTopic.typedRole → Abstract, source context clause 2; sourceTopic.typedRole → Abstract, source context clause 3; sourceTopic.typedRole → Abstract, source context clause 4; sourceTopic.typedRole → Abstract, source context clause 5; sourceTopic.typedRole → Abstract, source context clause 6; sourceTopic.typedRole → Abstract, source context clause 7; sourceTopic.typedRole → Abstract, source context clause 8)

Read the full paper explanation

Optional audio and transcript

Audio reading

Read this exact transcript with an on-device browser voice. Checks the current public source version and starts only when you press Play; no audio provider or upload. Availability depends on this browser’s local voices.

Checking for a local voice…

Complete versioned transcript

Versioned snapshot of this displayed record. It may no longer be current; audio requires a successful current-version check.

Training, detraining and retraining findings Stable finding ID: finding:examine2025:39364857:1. Finding version: 2. Revision: finding:examine2025:39364857:1:v2. Content hash: sha256:6a10c441bd858c17ff9b87c4f4eebc5a0257747201fdd8879be541359878a0f9. Paper version: 3. Paper content hash: sha256:2bdb127f3ee25c92a6bf1cb57b2a3eaeea3b9dddd26c082f3a18001ee72c7e56. AI-extracted — pending human review Source-authored record; platform synthesis is not enabled for this record. Publication status: published. Reported arm completers: CRT 22; PRT 20. randomized parallel training sequences. 55 randomized participants. Analysis population: unclear. Authors-reported finding: Reported arm completers: CRT 22; PRT 20.. Authors-reported finding: leg press one repetition maximum — PRT versus CRT; postintervention authors-named postintervention window. No detected between-group difference. Authors-reported finding: leg press one repetition maximum — Within PRT during the named phase; 10-week detraining period in PRT after the first 10-week resistance-training period. Decrease within the stated arm and phase. Source reported p < 0.05 for the outcome bundle (leg press one repetition maximum, biceps curl one repetition maximum, vastus lateralis muscle cross-sectional area, biceps brachii muscle cross-sectional area, countermovement jump height). Authors-reported finding: biceps curl one repetition maximum — PRT versus CRT; postintervention authors-named postintervention window. No detected between-group difference. Authors-reported finding: biceps curl one repetition maximum — Within PRT during the named phase; 10-week detraining period in PRT after the first 10-week resistance-training period. Decrease within the stated arm and phase. Source reported p < 0.05 for the outcome bundle (leg press one repetition maximum, biceps curl one repetition maximum, vastus lateralis muscle cross-sectional area, biceps brachii muscle cross-sectional area, countermovement jump height). Authors-reported finding: vastus lateralis muscle cross-sectional area — PRT versus CRT; postintervention authors-named postintervention window. No detected between-group difference. Authors-reported finding: vastus lateralis muscle cross-sectional area — Within PRT during the named phase; 10-week detraining period in PRT after the first 10-week resistance-training period. Decrease within the stated arm and phase. Source reported p < 0.05 for the outcome bundle (leg press one repetition maximum, biceps curl one repetition maximum, vastus lateralis muscle cross-sectional area, biceps brachii muscle cross-sectional area, countermovement jump height). Authors-reported finding: biceps brachii muscle cross-sectional area — PRT versus CRT; postintervention authors-named postintervention window. No detected between-group difference. Authors-reported finding: biceps brachii muscle cross-sectional area — Within PRT during the named phase; 10-week detraining period in PRT after the first 10-week resistance-training period. Decrease within the stated arm and phase. Source reported p < 0.05 for the outcome bundle (leg press one repetition maximum, biceps curl one repetition maximum, vastus lateralis muscle cross-sectional area, biceps brachii muscle cross-sectional area, countermovement jump height). Authors-reported finding: countermovement jump height — PRT versus CRT; postintervention authors-named postintervention window. No detected between-group difference. Authors-reported finding: countermovement jump height — Within PRT during the named phase; 10-week detraining period in PRT after the first 10-week resistance-training period. Decrease within the stated arm and phase. Source reported p < 0.05 for the outcome bundle (leg press one repetition maximum, biceps curl one repetition maximum, vastus lateralis muscle cross-sectional area, biceps brachii muscle cross-sectional area, countermovement jump height). Authors-reported finding: leg press one repetition maximum — PRT versus CRT; first 5 weeks of retraining in PRT start of retraining after detraining. Compared phases: PRT first 5 weeks of retraining in PRT start of retraining after detraining; CRT Weeks 10-15 of CRT authors-named CRT phase. Greater in the stated experimental group at the compared phases. Source reported p < 0.01 for the outcome bundle (leg press one repetition maximum, vastus lateralis muscle cross-sectional area, biceps brachii muscle cross-sectional area). Authors-reported finding: vastus lateralis muscle cross-sectional area — PRT versus CRT; first 5 weeks of retraining in PRT start of retraining after detraining. Compared phases: PRT first 5 weeks of retraining in PRT start of retraining after detraining; CRT Weeks 10-15 of CRT authors-named CRT phase. Greater in the stated experimental group at the compared phases. Source reported p < 0.01 for the outcome bundle (leg press one repetition maximum, vastus lateralis muscle cross-sectional area, biceps brachii muscle cross-sectional area). Authors-reported finding: biceps brachii muscle cross-sectional area — PRT versus CRT; first 5 weeks of retraining in PRT start of retraining after detraining. Compared phases: PRT first 5 weeks of retraining in PRT start of retraining after detraining; CRT Weeks 10-15 of CRT authors-named CRT phase. Greater in the stated experimental group at the compared phases. Source reported p < 0.01 for the outcome bundle (leg press one repetition maximum, vastus lateralis muscle cross-sectional area, biceps brachii muscle cross-sectional area). Each record retains its source-reported context and uncertainty. Reported limitation: Authors-reported study comparisons and phases; no platform pooling. Reported limitation: Completer counts are not randomized arm sizes. Reported limitation: No detected difference is not equivalence or noninferiority. Reported limitation: No numerical effect estimate or cross-phase contrast is computed. Reported limitation: Threshold p values belong to the source-reported outcome bundle, not independently asserted outcome tests. Reported limitation: The abstract reports no between-group differences and similar postintervention adaptations; no endpoint-specific test or equivalence is inferred. Reported limitation: Completer counts are not randomized arm sizes. Reported limitation: No detected difference is not equivalence or noninferiority. Reported limitation: No numerical effect estimate or cross-phase contrast is computed. Reported limitation: Threshold p values belong to the source-reported outcome bundle, not independently asserted outcome tests. Reported limitation: The abstract reports no between-group differences and similar postintervention adaptations; no endpoint-specific test or equivalence is inferred. Reported limitation: Within-arm change during detraining; not a randomized between-group effect. Reported limitation: Completer counts are not randomized arm sizes. Reported limitation: No detected difference is not equivalence or noninferiority. Reported limitation: No numerical effect estimate or cross-phase contrast is computed. Reported limitation: Threshold p values belong to the source-reported outcome bundle, not independently asserted outcome tests. Reported limitation: The abstract reports no between-group differences and similar postintervention adaptations; no endpoint-specific test or equivalence is inferred. Reported limitation: Completer counts are not randomized arm sizes. Reported limitation: No detected difference is not equivalence or noninferiority. Reported limitation: No numerical effect estimate or cross-phase contrast is computed. Reported limitation: Threshold p values belong to the source-reported outcome bundle, not independently asserted outcome tests. Reported limitation: The abstract reports no between-group differences and similar postintervention adaptations; no endpoint-specific test or equivalence is inferred. Reported limitation: Within-arm change during detraining; not a randomized between-group effect. Reported limitation: Completer counts are not randomized arm sizes. Reported limitation: No detected difference is not equivalence or noninferiority. Reported limitation: No numerical effect estimate or cross-phase contrast is computed. Reported limitation: Threshold p values belong to the source-reported outcome bundle, not independently asserted outcome tests. Reported limitation: The abstract reports no between-group differences and similar postintervention adaptations; no endpoint-specific test or equivalence is inferred. Reported limitation: Completer counts are not randomized arm sizes. Reported limitation: No detected difference is not equivalence or noninferiority. Reported limitation: No numerical effect estimate or cross-phase contrast is computed. Reported limitation: Threshold p values belong to the source-reported outcome bundle, not independently asserted outcome tests. Reported limitation: The abstract reports no between-group differences and similar postintervention adaptations; no endpoint-specific test or equivalence is inferred. Reported limitation: Within-arm change during detraining; not a randomized between-group effect. Reported limitation: Completer counts are not randomized arm sizes. Reported limitation: No detected difference is not equivalence or noninferiority. Reported limitation: No numerical effect estimate or cross-phase contrast is computed. Reported limitation: Threshold p values belong to the source-reported outcome bundle, not independently asserted outcome tests. Reported limitation: The abstract reports no between-group differences and similar postintervention adaptations; no endpoint-specific test or equivalence is inferred. Reported limitation: Completer counts are not randomized arm sizes. Reported limitation: No detected difference is not equivalence or noninferiority. Reported limitation: No numerical effect estimate or cross-phase contrast is computed. Reported limitation: Threshold p values belong to the source-reported outcome bundle, not independently asserted outcome tests. Reported limitation: The abstract reports no between-group differences and similar postintervention adaptations; no endpoint-specific test or equivalence is inferred. Reported limitation: Within-arm change during detraining; not a randomized between-group effect. Reported limitation: Completer counts are not randomized arm sizes. Reported limitation: No detected difference is not equivalence or noninferiority. Reported limitation: No numerical effect estimate or cross-phase contrast is computed. Reported limitation: Threshold p values belong to the source-reported outcome bundle, not independently asserted outcome tests. Reported limitation: The abstract reports no between-group differences and similar postintervention adaptations; no endpoint-specific test or equivalence is inferred. Reported limitation: Completer counts are not randomized arm sizes. Reported limitation: No detected difference is not equivalence or noninferiority. Reported limitation: No numerical effect estimate or cross-phase contrast is computed. Reported limitation: Threshold p values belong to the source-reported outcome bundle, not independently asserted outcome tests. Reported limitation: The abstract reports no between-group differences and similar postintervention adaptations; no endpoint-specific test or equivalence is inferred. Reported limitation: Within-arm change during detraining; not a randomized between-group effect. Reported limitation: Completer counts are not randomized arm sizes. Reported limitation: No detected difference is not equivalence or noninferiority. Reported limitation: No numerical effect estimate or cross-phase contrast is computed. Reported limitation: Threshold p values belong to the source-reported outcome bundle, not independently asserted outcome tests. Reported limitation: The abstract reports no between-group differences and similar postintervention adaptations; no endpoint-specific test or equivalence is inferred. Reported limitation: Completer counts are not randomized arm sizes. Reported limitation: No detected difference is not equivalence or noninferiority. Reported limitation: No numerical effect estimate or cross-phase contrast is computed. Reported limitation: Threshold p values belong to the source-reported outcome bundle, not independently asserted outcome tests. Reported limitation: The abstract reports no between-group differences and similar postintervention adaptations; no endpoint-specific test or equivalence is inferred. Reported limitation: Completer counts are not randomized arm sizes. Reported limitation: No detected difference is not equivalence or noninferiority. Reported limitation: No numerical effect estimate or cross-phase contrast is computed. Reported limitation: Threshold p values belong to the source-reported outcome bundle, not independently asserted outcome tests. Reported limitation: The abstract reports no between-group differences and similar postintervention adaptations; no endpoint-specific test or equivalence is inferred. Finding revision: finding:examine2025:39364857:1:v2. Finding version: 2. Finding content hash: sha256:6a10c441bd858c17ff9b87c4f4eebc5a0257747201fdd8879be541359878a0f9. Paper version: 3. Paper version content hash: sha256:2bdb127f3ee25c92a6bf1cb57b2a3eaeea3b9dddd26c082f3a18001ee72c7e56. Source content hash: sha256:c02eb924c0ded4a811423052557666500846d5fc5925ccab4f228919d8a868fb. Extraction policy: context164-source-topic-policy:d2c863b8d9f94acf3a7378bfa6e49a23bd72eea4408a689b542d3f7244fd7bfb. Extraction policy hash: sha256:d2c863b8d9f94acf3a7378bfa6e49a23bd72eea4408a689b542d3f7244fd7bfb. Extraction method version: source-reported-records/v1. Field locators: study_comparisons.clause0 → https://eutils.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&id=39364857&rettype=abstract&retmode=text: abstract:624-829; study_comparisons.clause1 → https://eutils.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&id=39364857&rettype=abstract&retmode=text: abstract:830-914; study_comparisons.clause2 → https://eutils.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&id=39364857&rettype=abstract&retmode=text: abstract:915-973; study_comparisons.clause3 → https://eutils.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&id=39364857&rettype=abstract&retmode=text: abstract:1034-1326; study_comparisons.clause4 → https://eutils.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&id=39364857&rettype=abstract&retmode=text: abstract:1327-1451; study_comparisons.clause5 → https://eutils.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&id=39364857&rettype=abstract&retmode=text: abstract:1452-1550; study_comparisons.clause6 → https://eutils.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&id=39364857&rettype=abstract&retmode=text: abstract:1551-1705; study_comparisons.clause7 → https://eutils.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&id=39364857&rettype=abstract&retmode=text: abstract:1706-1866. Source document: https://eutils.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&id=39364857&rettype=abstract&retmode=text. Source hash: sha256:c02eb924c0ded4a811423052557666500846d5fc5925ccab4f228919d8a868fb. Locators: study_comparisons.clause0: abstract:624-829; study_comparisons.clause1: abstract:830-914; study_comparisons.clause2: abstract:915-973; study_comparisons.clause3: abstract:1034-1326; study_comparisons.clause4: abstract:1327-1451; study_comparisons.clause5: abstract:1452-1550; study_comparisons.clause6: abstract:1551-1705; study_comparisons.clause7: abstract:1706-1866; study_comparisons.clause0: abstract:624-829; study_comparisons.clause1: abstract:830-914; study_comparisons.clause2: abstract:915-973; study_comparisons.clause3: abstract:1034-1326; study_comparisons.clause4: abstract:1327-1451; study_comparisons.clause5: abstract:1452-1550; study_comparisons.clause6: abstract:1551-1705; study_comparisons.clause7: abstract:1706-1866; sourceTopic.typedRole: Abstract, source context clause 1; sourceTopic.typedRole: Abstract, source context clause 2; sourceTopic.typedRole: Abstract, source context clause 3; sourceTopic.typedRole: Abstract, source context clause 4; sourceTopic.typedRole: Abstract, source context clause 5; sourceTopic.typedRole: Abstract, source context clause 6; sourceTopic.typedRole: Abstract, source context clause 7; sourceTopic.typedRole: Abstract, source context clause 8; study_comparisons.clause0: abstract:624-829; study_comparisons.clause1: abstract:830-914; study_comparisons.clause2: abstract:915-973; study_comparisons.clause3: abstract:1034-1326; study_comparisons.clause4: abstract:1327-1451; study_comparisons.clause5: abstract:1452-1550; study_comparisons.clause6: abstract:1551-1705; study_comparisons.clause7: abstract:1706-1866; sourceTopic.typedRole: Abstract, source context clause 1; sourceTopic.typedRole: Abstract, source context clause 2; sourceTopic.typedRole: Abstract, source context clause 3; sourceTopic.typedRole: Abstract, source context clause 4; sourceTopic.typedRole: Abstract, source context clause 5; sourceTopic.typedRole: Abstract, source context clause 6; sourceTopic.typedRole: Abstract, source context clause 7; sourceTopic.typedRole: Abstract, source context clause 8; study_comparisons.clause0: abstract:624-829; study_comparisons.clause1: abstract:830-914; study_comparisons.clause2: abstract:915-973; study_comparisons.clause3: abstract:1034-1326; study_comparisons.clause4: abstract:1327-1451; study_comparisons.clause5: abstract:1452-1550; study_comparisons.clause6: abstract:1551-1705; study_comparisons.clause7: abstract:1706-1866; sourceTopic.typedRole: Abstract, source context clause 1; sourceTopic.typedRole: Abstract, source context clause 2; sourceTopic.typedRole: Abstract, source context clause 3; sourceTopic.typedRole: Abstract, source context clause 4; sourceTopic.typedRole: Abstract, source context clause 5; sourceTopic.typedRole: Abstract, source context clause 6; sourceTopic.typedRole: Abstract, source context clause 7; sourceTopic.typedRole: Abstract, source context clause 8; study_comparisons.clause0: abstract:624-829; study_comparisons.clause1: abstract:830-914; study_comparisons.clause2: abstract:915-973; study_comparisons.clause3: abstract:1034-1326; study_comparisons.clause4: abstract:1327-1451; study_comparisons.clause5: abstract:1452-1550; study_comparisons.clause6: abstract:1551-1705; study_comparisons.clause7: abstract:1706-1866; sourceTopic.typedRole: Abstract, source context clause 1; sourceTopic.typedRole: Abstract, source context clause 2; sourceTopic.typedRole: Abstract, source context clause 3; sourceTopic.typedRole: Abstract, source context clause 4; sourceTopic.typedRole: Abstract, source context clause 5; sourceTopic.typedRole: Abstract, source context clause 6; sourceTopic.typedRole: Abstract, source context clause 7; sourceTopic.typedRole: Abstract, source context clause 8. Canonical paper: /studies/39364857. This is a reading of this version, not a clinical recommendation. Check the current paper page for updates.

Read the full paper explanation →Original source · Bring into My Profile

Study context, unresolved fields and interpretation limits

What this paper reported

Source-anchored extracted record
AI-extracted — pending human review
Source status is not human clinical review.
Authors-reported records; platform synthesis is not enabled.

These records restate the authors’ findings with their own comparisons, source windows and uncertainty. They are pending human review and are not a platform synthesis or recommendation.

What the paper set out to compare: Not available in this record
Who was studied: randomized parallel training sequences. 55 randomized participants. Analysis population: unclear.
How it was designed: randomized_parallel_training_sequences
Studied intervention: Not available in this record
Compared against: Not available in this record
What was measured, and when: Training, detraining and retraining findings
What the authors reported: Reported arm completers: CRT 22; PRT 20. leg press one repetition maximum — PRT versus CRT; postintervention authors-named postintervention window. No detected between-group difference leg press one repetition maximum — Within PRT during the named phase; 10-week detraining period in PRT after the first 10-week resistance-training period. Decrease within the stated arm and phase. Source reported p < 0.05 for the outcome bundle (leg press one repetition maximum, biceps curl one repetition maximum, vastus lateralis muscle cross-sectional area, biceps brachii muscle cross-sectional area, countermovement jump height) biceps curl one repetition maximum — PRT versus CRT; postintervention authors-named postintervention window. No detected between-group difference biceps curl one repetition maximum — Within PRT during the named phase; 10-week detraining period in PRT after the first 10-week resistance-training period. Decrease within the stated arm and phase. Source reported p < 0.05 for the outcome bundle (leg press one repetition maximum, biceps curl one repetition maximum, vastus lateralis muscle cross-sectional area, biceps brachii muscle cross-sectional area, countermovement jump height) vastus lateralis muscle cross-sectional area — PRT versus CRT; postintervention authors-named postintervention window. No detected between-group difference vastus lateralis muscle cross-sectional area — Within PRT during the named phase; 10-week detraining period in PRT after the first 10-week resistance-training period. Decrease within the stated arm and phase. Source reported p < 0.05 for the outcome bundle (leg press one repetition maximum, biceps curl one repetition maximum, vastus lateralis muscle cross-sectional area, biceps brachii muscle cross-sectional area, countermovement jump height) biceps brachii muscle cross-sectional area — PRT versus CRT; postintervention authors-named postintervention window. No detected between-group difference biceps brachii muscle cross-sectional area — Within PRT during the named phase; 10-week detraining period in PRT after the first 10-week resistance-training period. Decrease within the stated arm and phase. Source reported p < 0.05 for the outcome bundle (leg press one repetition maximum, biceps curl one repetition maximum, vastus lateralis muscle cross-sectional area, biceps brachii muscle cross-sectional area, countermovement jump height) countermovement jump height — PRT versus CRT; postintervention authors-named postintervention window. No detected between-group difference countermovement jump height — Within PRT during the named phase; 10-week detraining period in PRT after the first 10-week resistance-training period. Decrease within the stated arm and phase. Source reported p < 0.05 for the outcome bundle (leg press one repetition maximum, biceps curl one repetition maximum, vastus lateralis muscle cross-sectional area, biceps brachii muscle cross-sectional area, countermovement jump height) leg press one repetition maximum — PRT versus CRT; first 5 weeks of retraining in PRT start of retraining after detraining. Compared phases: PRT first 5 weeks of retraining in PRT start of retraining after detraining; CRT Weeks 10-15 of CRT authors-named CRT phase. Greater in the stated experimental group at the compared phases. Source reported p < 0.01 for the outcome bundle (leg press one repetition maximum, vastus lateralis muscle cross-sectional area, biceps brachii muscle cross-sectional area) vastus lateralis muscle cross-sectional area — PRT versus CRT; first 5 weeks of retraining in PRT start of retraining after detraining. Compared phases: PRT first 5 weeks of retraining in PRT start of retraining after detraining; CRT Weeks 10-15 of CRT authors-named CRT phase. Greater in the stated experimental group at the compared phases. Source reported p < 0.01 for the outcome bundle (leg press one repetition maximum, vastus lateralis muscle cross-sectional area, biceps brachii muscle cross-sectional area) biceps brachii muscle cross-sectional area — PRT versus CRT; first 5 weeks of retraining in PRT start of retraining after detraining. Compared phases: PRT first 5 weeks of retraining in PRT start of retraining after detraining; CRT Weeks 10-15 of CRT authors-named CRT phase. Greater in the stated experimental group at the compared phases. Source reported p < 0.01 for the outcome bundle (leg press one repetition maximum, vastus lateralis muscle cross-sectional area, biceps brachii muscle cross-sectional area)

Fields marked not available are not encoded in this source record and have not been inferred.

Fields awaiting review

Supported findings remain available. These field records keep unresolved context separate.

population — not extractable by the current method: This field is not yet encoded in a verified structured record; the source may contain supported information. Check this source version and record its supported context, retaining the study comparisons and uncertainty. Check the source
Review history · version 1
Source version: pubmed:39364857:abstract:sha256:7a56c70363bf9b01e1ff346460bda44b713f9e39460821a24b6cef194c282b45
No resolution has been recorded.
intervention — not extractable by the current method: This field is not yet encoded in a verified structured record; the source may contain supported information. Check this source version and record its supported context, retaining the study comparisons and uncertainty. Check the source
Review history · version 1
Source version: pubmed:39364857:abstract:sha256:7a56c70363bf9b01e1ff346460bda44b713f9e39460821a24b6cef194c282b45
No resolution has been recorded.
comparator — not extractable by the current method: This field is not yet encoded in a verified structured record; the source may contain supported information. Check this source version and record its supported context, retaining the study comparisons and uncertainty. Check the source
Review history · version 1
Source version: pubmed:39364857:abstract:sha256:7a56c70363bf9b01e1ff346460bda44b713f9e39460821a24b6cef194c282b45
No resolution has been recorded.
sample Size — not extractable by the current method: This field is not yet encoded in a verified structured record; the source may contain supported information. Check this source version and record its supported context, retaining the study comparisons and uncertainty. Check the source
Review history · version 1
Source version: pubmed:39364857:abstract:sha256:7a56c70363bf9b01e1ff346460bda44b713f9e39460821a24b6cef194c282b45
No resolution has been recorded.
analysis Population — not extractable by the current method: This field is not yet encoded in a verified structured record; the source may contain supported information. Check this source version and record its supported context, retaining the study comparisons and uncertainty. Check the source
Review history · version 1
Source version: pubmed:39364857:abstract:sha256:7a56c70363bf9b01e1ff346460bda44b713f9e39460821a24b6cef194c282b45
No resolution has been recorded.
adjustment — not extractable by the current method: This field is not yet encoded in a verified structured record; the source may contain supported information. Check this source version and record its supported context, retaining the study comparisons and uncertainty. Check the source
Review history · version 1
Source version: pubmed:39364857:abstract:sha256:7a56c70363bf9b01e1ff346460bda44b713f9e39460821a24b6cef194c282b45
No resolution has been recorded.
uncertainty — not extractable by the current method: This field is not yet encoded in a verified structured record; the source may contain supported information. Check this source version and record its supported context, retaining the study comparisons and uncertainty. Check the source
Review history · version 1
Source version: pubmed:39364857:abstract:sha256:7a56c70363bf9b01e1ff346460bda44b713f9e39460821a24b6cef194c282b45
No resolution has been recorded.
subgroup — not extractable by the current method: This field is not yet encoded in a verified structured record; the source may contain supported information. Check this source version and record its supported context, retaining the study comparisons and uncertainty. Check the source
Review history · version 1
Source version: pubmed:39364857:abstract:sha256:7a56c70363bf9b01e1ff346460bda44b713f9e39460821a24b6cef194c282b45
No resolution has been recorded.
interaction — not extractable by the current method: This field is not yet encoded in a verified structured record; the source may contain supported information. Check this source version and record its supported context, retaining the study comparisons and uncertainty. Check the source
Review history · version 1
Source version: pubmed:39364857:abstract:sha256:7a56c70363bf9b01e1ff346460bda44b713f9e39460821a24b6cef194c282b45
No resolution has been recorded.

Field review history

outcomes — Supported field recorded in a source finding

Source version: pubmed:39364857:abstract:sha256:7a56c70363bf9b01e1ff346460bda44b713f9e39460821a24b6cef194c282b45 · Check the source

Version 2: verified supported · finding finding:examine2025:39364857:1:v1

timepoint — Supported field recorded in a source finding

Source version: pubmed:39364857:abstract:sha256:7a56c70363bf9b01e1ff346460bda44b713f9e39460821a24b6cef194c282b45 · Check the source

Version 2: verified supported · finding finding:examine2025:39364857:1:v1

contrast — Supported field recorded in a source finding

Source version: pubmed:39364857:abstract:sha256:7a56c70363bf9b01e1ff346460bda44b713f9e39460821a24b6cef194c282b45 · Check the source

Version 2: verified supported · finding finding:examine2025:39364857:1:v1

Limitations and interpretation bounds

Authors-reported study comparisons and phases; no platform pooling.
Completer counts are not randomized arm sizes.
No detected difference is not equivalence or noninferiority.
No numerical effect estimate or cross-phase contrast is computed.
Threshold p values belong to the source-reported outcome bundle, not independently asserted outcome tests.
The abstract reports no between-group differences and similar postintervention adaptations; no endpoint-specific test or equivalence is inferred.
Completer counts are not randomized arm sizes.
No detected difference is not equivalence or noninferiority.
No numerical effect estimate or cross-phase contrast is computed.
Threshold p values belong to the source-reported outcome bundle, not independently asserted outcome tests.
The abstract reports no between-group differences and similar postintervention adaptations; no endpoint-specific test or equivalence is inferred.
Within-arm change during detraining; not a randomized between-group effect.
Completer counts are not randomized arm sizes.
No detected difference is not equivalence or noninferiority.
No numerical effect estimate or cross-phase contrast is computed.
Threshold p values belong to the source-reported outcome bundle, not independently asserted outcome tests.
The abstract reports no between-group differences and similar postintervention adaptations; no endpoint-specific test or equivalence is inferred.
Completer counts are not randomized arm sizes.
No detected difference is not equivalence or noninferiority.
No numerical effect estimate or cross-phase contrast is computed.
Threshold p values belong to the source-reported outcome bundle, not independently asserted outcome tests.
The abstract reports no between-group differences and similar postintervention adaptations; no endpoint-specific test or equivalence is inferred.
Within-arm change during detraining; not a randomized between-group effect.
Completer counts are not randomized arm sizes.
No detected difference is not equivalence or noninferiority.
No numerical effect estimate or cross-phase contrast is computed.
Threshold p values belong to the source-reported outcome bundle, not independently asserted outcome tests.
The abstract reports no between-group differences and similar postintervention adaptations; no endpoint-specific test or equivalence is inferred.
Completer counts are not randomized arm sizes.
No detected difference is not equivalence or noninferiority.
No numerical effect estimate or cross-phase contrast is computed.
Threshold p values belong to the source-reported outcome bundle, not independently asserted outcome tests.
The abstract reports no between-group differences and similar postintervention adaptations; no endpoint-specific test or equivalence is inferred.
Within-arm change during detraining; not a randomized between-group effect.
Completer counts are not randomized arm sizes.
No detected difference is not equivalence or noninferiority.
No numerical effect estimate or cross-phase contrast is computed.
Threshold p values belong to the source-reported outcome bundle, not independently asserted outcome tests.
The abstract reports no between-group differences and similar postintervention adaptations; no endpoint-specific test or equivalence is inferred.
Completer counts are not randomized arm sizes.
No detected difference is not equivalence or noninferiority.
No numerical effect estimate or cross-phase contrast is computed.
Threshold p values belong to the source-reported outcome bundle, not independently asserted outcome tests.
The abstract reports no between-group differences and similar postintervention adaptations; no endpoint-specific test or equivalence is inferred.
Within-arm change during detraining; not a randomized between-group effect.
Completer counts are not randomized arm sizes.
No detected difference is not equivalence or noninferiority.
No numerical effect estimate or cross-phase contrast is computed.
Threshold p values belong to the source-reported outcome bundle, not independently asserted outcome tests.
The abstract reports no between-group differences and similar postintervention adaptations; no endpoint-specific test or equivalence is inferred.
Completer counts are not randomized arm sizes.
No detected difference is not equivalence or noninferiority.
No numerical effect estimate or cross-phase contrast is computed.
Threshold p values belong to the source-reported outcome bundle, not independently asserted outcome tests.
The abstract reports no between-group differences and similar postintervention adaptations; no endpoint-specific test or equivalence is inferred.
Within-arm change during detraining; not a randomized between-group effect.
Completer counts are not randomized arm sizes.
No detected difference is not equivalence or noninferiority.
No numerical effect estimate or cross-phase contrast is computed.
Threshold p values belong to the source-reported outcome bundle, not independently asserted outcome tests.
The abstract reports no between-group differences and similar postintervention adaptations; no endpoint-specific test or equivalence is inferred.
Completer counts are not randomized arm sizes.
No detected difference is not equivalence or noninferiority.
No numerical effect estimate or cross-phase contrast is computed.
Threshold p values belong to the source-reported outcome bundle, not independently asserted outcome tests.
The abstract reports no between-group differences and similar postintervention adaptations; no endpoint-specific test or equivalence is inferred.
Completer counts are not randomized arm sizes.
No detected difference is not equivalence or noninferiority.
No numerical effect estimate or cross-phase contrast is computed.
Threshold p values belong to the source-reported outcome bundle, not independently asserted outcome tests.
The abstract reports no between-group differences and similar postintervention adaptations; no endpoint-specific test or equivalence is inferred.

Source-linked brief with study context, limitations and exact record versions.

PubMed study 39364857

Substrate paper brief · PMID 39364857

Study publication year: Not available in this record. Retrieved: 2026-10-16T23:10:11.589Z.

https://evidencebased.info/studies/39364857
https://pubmed.ncbi.nlm.nih.gov/39364857/

This is a dated public record snapshot. Check the canonical study page for later publication, withdrawal or review changes. It is not a recommendation or human clinical review.

Quick takeaway

Reported arm completers: CRT 22; PRT 20.

randomized parallel training sequences. 55 randomized participants. Analysis population: unclear.

What this paper studied

These records restate the authors’ findings with their own comparisons, source windows and uncertainty. They are pending human review and are not a platform synthesis or recommendation.

AI-extracted — pending human review
Source status is not human clinical review.
Authors-reported records; platform synthesis is not enabled.

What the paper set out to compare: Not available in this record
Who was studied: randomized parallel training sequences. 55 randomized participants. Analysis population: unclear.
How it was designed: randomized_parallel_training_sequences
Studied intervention: Not available in this record
Compared against: Not available in this record
What was measured, and when: Training, detraining and retraining findings
What the authors reported: Reported arm completers: CRT 22; PRT 20. leg press one repetition maximum — PRT versus CRT; postintervention authors-named postintervention window. No detected between-group difference leg press one repetition maximum — Within PRT during the named phase; 10-week detraining period in PRT after the first 10-week resistance-training period. Decrease within the stated arm and phase. Source reported p < 0.05 for the outcome bundle (leg press one repetition maximum, biceps curl one repetition maximum, vastus lateralis muscle cross-sectional area, biceps brachii muscle cross-sectional area, countermovement jump height) biceps curl one repetition maximum — PRT versus CRT; postintervention authors-named postintervention window. No detected between-group difference biceps curl one repetition maximum — Within PRT during the named phase; 10-week detraining period in PRT after the first 10-week resistance-training period. Decrease within the stated arm and phase. Source reported p < 0.05 for the outcome bundle (leg press one repetition maximum, biceps curl one repetition maximum, vastus lateralis muscle cross-sectional area, biceps brachii muscle cross-sectional area, countermovement jump height) vastus lateralis muscle cross-sectional area — PRT versus CRT; postintervention authors-named postintervention window. No detected between-group difference vastus lateralis muscle cross-sectional area — Within PRT during the named phase; 10-week detraining period in PRT after the first 10-week resistance-training period. Decrease within the stated arm and phase. Source reported p < 0.05 for the outcome bundle (leg press one repetition maximum, biceps curl one repetition maximum, vastus lateralis muscle cross-sectional area, biceps brachii muscle cross-sectional area, countermovement jump height) biceps brachii muscle cross-sectional area — PRT versus CRT; postintervention authors-named postintervention window. No detected between-group difference biceps brachii muscle cross-sectional area — Within PRT during the named phase; 10-week detraining period in PRT after the first 10-week resistance-training period. Decrease within the stated arm and phase. Source reported p < 0.05 for the outcome bundle (leg press one repetition maximum, biceps curl one repetition maximum, vastus lateralis muscle cross-sectional area, biceps brachii muscle cross-sectional area, countermovement jump height) countermovement jump height — PRT versus CRT; postintervention authors-named postintervention window. No detected between-group difference countermovement jump height — Within PRT during the named phase; 10-week detraining period in PRT after the first 10-week resistance-training period. Decrease within the stated arm and phase. Source reported p < 0.05 for the outcome bundle (leg press one repetition maximum, biceps curl one repetition maximum, vastus lateralis muscle cross-sectional area, biceps brachii muscle cross-sectional area, countermovement jump height) leg press one repetition maximum — PRT versus CRT; first 5 weeks of retraining in PRT start of retraining after detraining. Compared phases: PRT first 5 weeks of retraining in PRT start of retraining after detraining; CRT Weeks 10-15 of CRT authors-named CRT phase. Greater in the stated experimental group at the compared phases. Source reported p < 0.01 for the outcome bundle (leg press one repetition maximum, vastus lateralis muscle cross-sectional area, biceps brachii muscle cross-sectional area) vastus lateralis muscle cross-sectional area — PRT versus CRT; first 5 weeks of retraining in PRT start of retraining after detraining. Compared phases: PRT first 5 weeks of retraining in PRT start of retraining after detraining; CRT Weeks 10-15 of CRT authors-named CRT phase. Greater in the stated experimental group at the compared phases. Source reported p < 0.01 for the outcome bundle (leg press one repetition maximum, vastus lateralis muscle cross-sectional area, biceps brachii muscle cross-sectional area) biceps brachii muscle cross-sectional area — PRT versus CRT; first 5 weeks of retraining in PRT start of retraining after detraining. Compared phases: PRT first 5 weeks of retraining in PRT start of retraining after detraining; CRT Weeks 10-15 of CRT authors-named CRT phase. Greater in the stated experimental group at the compared phases. Source reported p < 0.01 for the outcome bundle (leg press one repetition maximum, vastus lateralis muscle cross-sectional area, biceps brachii muscle cross-sectional area)

Fields marked not available are not encoded in this source record and have not been inferred.

Study limitations and interpretation bounds

Authors-reported study comparisons and phases; no platform pooling.
Completer counts are not randomized arm sizes.
No detected difference is not equivalence or noninferiority.
No numerical effect estimate or cross-phase contrast is computed.
Threshold p values belong to the source-reported outcome bundle, not independently asserted outcome tests.
The abstract reports no between-group differences and similar postintervention adaptations; no endpoint-specific test or equivalence is inferred.
Completer counts are not randomized arm sizes.
No detected difference is not equivalence or noninferiority.
No numerical effect estimate or cross-phase contrast is computed.
Threshold p values belong to the source-reported outcome bundle, not independently asserted outcome tests.
The abstract reports no between-group differences and similar postintervention adaptations; no endpoint-specific test or equivalence is inferred.
Within-arm change during detraining; not a randomized between-group effect.
Completer counts are not randomized arm sizes.
No detected difference is not equivalence or noninferiority.
No numerical effect estimate or cross-phase contrast is computed.
Threshold p values belong to the source-reported outcome bundle, not independently asserted outcome tests.
The abstract reports no between-group differences and similar postintervention adaptations; no endpoint-specific test or equivalence is inferred.
Completer counts are not randomized arm sizes.
No detected difference is not equivalence or noninferiority.
No numerical effect estimate or cross-phase contrast is computed.
Threshold p values belong to the source-reported outcome bundle, not independently asserted outcome tests.
The abstract reports no between-group differences and similar postintervention adaptations; no endpoint-specific test or equivalence is inferred.
Within-arm change during detraining; not a randomized between-group effect.
Completer counts are not randomized arm sizes.
No detected difference is not equivalence or noninferiority.
No numerical effect estimate or cross-phase contrast is computed.
Threshold p values belong to the source-reported outcome bundle, not independently asserted outcome tests.
The abstract reports no between-group differences and similar postintervention adaptations; no endpoint-specific test or equivalence is inferred.
Completer counts are not randomized arm sizes.
No detected difference is not equivalence or noninferiority.
No numerical effect estimate or cross-phase contrast is computed.
Threshold p values belong to the source-reported outcome bundle, not independently asserted outcome tests.
The abstract reports no between-group differences and similar postintervention adaptations; no endpoint-specific test or equivalence is inferred.
Within-arm change during detraining; not a randomized between-group effect.
Completer counts are not randomized arm sizes.
No detected difference is not equivalence or noninferiority.
No numerical effect estimate or cross-phase contrast is computed.
Threshold p values belong to the source-reported outcome bundle, not independently asserted outcome tests.
The abstract reports no between-group differences and similar postintervention adaptations; no endpoint-specific test or equivalence is inferred.
Completer counts are not randomized arm sizes.
No detected difference is not equivalence or noninferiority.
No numerical effect estimate or cross-phase contrast is computed.
Threshold p values belong to the source-reported outcome bundle, not independently asserted outcome tests.
The abstract reports no between-group differences and similar postintervention adaptations; no endpoint-specific test or equivalence is inferred.
Within-arm change during detraining; not a randomized between-group effect.
Completer counts are not randomized arm sizes.
No detected difference is not equivalence or noninferiority.
No numerical effect estimate or cross-phase contrast is computed.
Threshold p values belong to the source-reported outcome bundle, not independently asserted outcome tests.
The abstract reports no between-group differences and similar postintervention adaptations; no endpoint-specific test or equivalence is inferred.
Completer counts are not randomized arm sizes.
No detected difference is not equivalence or noninferiority.
No numerical effect estimate or cross-phase contrast is computed.
Threshold p values belong to the source-reported outcome bundle, not independently asserted outcome tests.
The abstract reports no between-group differences and similar postintervention adaptations; no endpoint-specific test or equivalence is inferred.
Within-arm change during detraining; not a randomized between-group effect.
Completer counts are not randomized arm sizes.
No detected difference is not equivalence or noninferiority.
No numerical effect estimate or cross-phase contrast is computed.
Threshold p values belong to the source-reported outcome bundle, not independently asserted outcome tests.
The abstract reports no between-group differences and similar postintervention adaptations; no endpoint-specific test or equivalence is inferred.
Completer counts are not randomized arm sizes.
No detected difference is not equivalence or noninferiority.
No numerical effect estimate or cross-phase contrast is computed.
Threshold p values belong to the source-reported outcome bundle, not independently asserted outcome tests.
The abstract reports no between-group differences and similar postintervention adaptations; no endpoint-specific test or equivalence is inferred.
Completer counts are not randomized arm sizes.
No detected difference is not equivalence or noninferiority.
No numerical effect estimate or cross-phase contrast is computed.
Threshold p values belong to the source-reported outcome bundle, not independently asserted outcome tests.
The abstract reports no between-group differences and similar postintervention adaptations; no endpoint-specific test or equivalence is inferred.

Training, detraining and retraining findings

AI-extracted — pending human review
Source-authored record; platform synthesis is not enabled for this record.
Publication status: published.

Exact source-reported results

Each record retains its source-reported context and uncertainty.

Studied context

Authors-reported finding: Reported arm completers: CRT 22; PRT 20.
Authors-reported finding: leg press one repetition maximum — PRT versus CRT; postintervention authors-named postintervention window. No detected between-group difference
Authors-reported finding: leg press one repetition maximum — Within PRT during the named phase; 10-week detraining period in PRT after the first 10-week resistance-training period. Decrease within the stated arm and phase. Source reported p < 0.05 for the outcome bundle (leg press one repetition maximum, biceps curl one repetition maximum, vastus lateralis muscle cross-sectional area, biceps brachii muscle cross-sectional area, countermovement jump height)
Authors-reported finding: biceps curl one repetition maximum — PRT versus CRT; postintervention authors-named postintervention window. No detected between-group difference
Authors-reported finding: biceps curl one repetition maximum — Within PRT during the named phase; 10-week detraining period in PRT after the first 10-week resistance-training period. Decrease within the stated arm and phase. Source reported p < 0.05 for the outcome bundle (leg press one repetition maximum, biceps curl one repetition maximum, vastus lateralis muscle cross-sectional area, biceps brachii muscle cross-sectional area, countermovement jump height)
Authors-reported finding: vastus lateralis muscle cross-sectional area — PRT versus CRT; postintervention authors-named postintervention window. No detected between-group difference
Authors-reported finding: vastus lateralis muscle cross-sectional area — Within PRT during the named phase; 10-week detraining period in PRT after the first 10-week resistance-training period. Decrease within the stated arm and phase. Source reported p < 0.05 for the outcome bundle (leg press one repetition maximum, biceps curl one repetition maximum, vastus lateralis muscle cross-sectional area, biceps brachii muscle cross-sectional area, countermovement jump height)
Authors-reported finding: biceps brachii muscle cross-sectional area — PRT versus CRT; postintervention authors-named postintervention window. No detected between-group difference
Authors-reported finding: biceps brachii muscle cross-sectional area — Within PRT during the named phase; 10-week detraining period in PRT after the first 10-week resistance-training period. Decrease within the stated arm and phase. Source reported p < 0.05 for the outcome bundle (leg press one repetition maximum, biceps curl one repetition maximum, vastus lateralis muscle cross-sectional area, biceps brachii muscle cross-sectional area, countermovement jump height)
Authors-reported finding: countermovement jump height — PRT versus CRT; postintervention authors-named postintervention window. No detected between-group difference
Authors-reported finding: countermovement jump height — Within PRT during the named phase; 10-week detraining period in PRT after the first 10-week resistance-training period. Decrease within the stated arm and phase. Source reported p < 0.05 for the outcome bundle (leg press one repetition maximum, biceps curl one repetition maximum, vastus lateralis muscle cross-sectional area, biceps brachii muscle cross-sectional area, countermovement jump height)
Authors-reported finding: leg press one repetition maximum — PRT versus CRT; first 5 weeks of retraining in PRT start of retraining after detraining. Compared phases: PRT first 5 weeks of retraining in PRT start of retraining after detraining; CRT Weeks 10-15 of CRT authors-named CRT phase. Greater in the stated experimental group at the compared phases. Source reported p < 0.01 for the outcome bundle (leg press one repetition maximum, vastus lateralis muscle cross-sectional area, biceps brachii muscle cross-sectional area)
Authors-reported finding: vastus lateralis muscle cross-sectional area — PRT versus CRT; first 5 weeks of retraining in PRT start of retraining after detraining. Compared phases: PRT first 5 weeks of retraining in PRT start of retraining after detraining; CRT Weeks 10-15 of CRT authors-named CRT phase. Greater in the stated experimental group at the compared phases. Source reported p < 0.01 for the outcome bundle (leg press one repetition maximum, vastus lateralis muscle cross-sectional area, biceps brachii muscle cross-sectional area)
Authors-reported finding: biceps brachii muscle cross-sectional area — PRT versus CRT; first 5 weeks of retraining in PRT start of retraining after detraining. Compared phases: PRT first 5 weeks of retraining in PRT start of retraining after detraining; CRT Weeks 10-15 of CRT authors-named CRT phase. Greater in the stated experimental group at the compared phases. Source reported p < 0.01 for the outcome bundle (leg press one repetition maximum, vastus lateralis muscle cross-sectional area, biceps brachii muscle cross-sectional area)

Limitations

Authors-reported study comparisons and phases; no platform pooling.
Completer counts are not randomized arm sizes.
No detected difference is not equivalence or noninferiority.
No numerical effect estimate or cross-phase contrast is computed.
Threshold p values belong to the source-reported outcome bundle, not independently asserted outcome tests.
The abstract reports no between-group differences and similar postintervention adaptations; no endpoint-specific test or equivalence is inferred.
Completer counts are not randomized arm sizes.
No detected difference is not equivalence or noninferiority.
No numerical effect estimate or cross-phase contrast is computed.
Threshold p values belong to the source-reported outcome bundle, not independently asserted outcome tests.
The abstract reports no between-group differences and similar postintervention adaptations; no endpoint-specific test or equivalence is inferred.
Within-arm change during detraining; not a randomized between-group effect.
Completer counts are not randomized arm sizes.
No detected difference is not equivalence or noninferiority.
No numerical effect estimate or cross-phase contrast is computed.
Threshold p values belong to the source-reported outcome bundle, not independently asserted outcome tests.
The abstract reports no between-group differences and similar postintervention adaptations; no endpoint-specific test or equivalence is inferred.
Completer counts are not randomized arm sizes.
No detected difference is not equivalence or noninferiority.
No numerical effect estimate or cross-phase contrast is computed.
Threshold p values belong to the source-reported outcome bundle, not independently asserted outcome tests.
The abstract reports no between-group differences and similar postintervention adaptations; no endpoint-specific test or equivalence is inferred.
Within-arm change during detraining; not a randomized between-group effect.
Completer counts are not randomized arm sizes.
No detected difference is not equivalence or noninferiority.
No numerical effect estimate or cross-phase contrast is computed.
Threshold p values belong to the source-reported outcome bundle, not independently asserted outcome tests.
The abstract reports no between-group differences and similar postintervention adaptations; no endpoint-specific test or equivalence is inferred.
Completer counts are not randomized arm sizes.
No detected difference is not equivalence or noninferiority.
No numerical effect estimate or cross-phase contrast is computed.
Threshold p values belong to the source-reported outcome bundle, not independently asserted outcome tests.
The abstract reports no between-group differences and similar postintervention adaptations; no endpoint-specific test or equivalence is inferred.
Within-arm change during detraining; not a randomized between-group effect.
Completer counts are not randomized arm sizes.
No detected difference is not equivalence or noninferiority.
No numerical effect estimate or cross-phase contrast is computed.
Threshold p values belong to the source-reported outcome bundle, not independently asserted outcome tests.
The abstract reports no between-group differences and similar postintervention adaptations; no endpoint-specific test or equivalence is inferred.
Completer counts are not randomized arm sizes.
No detected difference is not equivalence or noninferiority.
No numerical effect estimate or cross-phase contrast is computed.
Threshold p values belong to the source-reported outcome bundle, not independently asserted outcome tests.
The abstract reports no between-group differences and similar postintervention adaptations; no endpoint-specific test or equivalence is inferred.
Within-arm change during detraining; not a randomized between-group effect.
Completer counts are not randomized arm sizes.
No detected difference is not equivalence or noninferiority.
No numerical effect estimate or cross-phase contrast is computed.
Threshold p values belong to the source-reported outcome bundle, not independently asserted outcome tests.
The abstract reports no between-group differences and similar postintervention adaptations; no endpoint-specific test or equivalence is inferred.
Completer counts are not randomized arm sizes.
No detected difference is not equivalence or noninferiority.
No numerical effect estimate or cross-phase contrast is computed.
Threshold p values belong to the source-reported outcome bundle, not independently asserted outcome tests.
The abstract reports no between-group differences and similar postintervention adaptations; no endpoint-specific test or equivalence is inferred.
Within-arm change during detraining; not a randomized between-group effect.
Completer counts are not randomized arm sizes.
No detected difference is not equivalence or noninferiority.
No numerical effect estimate or cross-phase contrast is computed.
Threshold p values belong to the source-reported outcome bundle, not independently asserted outcome tests.
The abstract reports no between-group differences and similar postintervention adaptations; no endpoint-specific test or equivalence is inferred.
Completer counts are not randomized arm sizes.
No detected difference is not equivalence or noninferiority.
No numerical effect estimate or cross-phase contrast is computed.
Threshold p values belong to the source-reported outcome bundle, not independently asserted outcome tests.
The abstract reports no between-group differences and similar postintervention adaptations; no endpoint-specific test or equivalence is inferred.
Completer counts are not randomized arm sizes.
No detected difference is not equivalence or noninferiority.
No numerical effect estimate or cross-phase contrast is computed.
Threshold p values belong to the source-reported outcome bundle, not independently asserted outcome tests.
The abstract reports no between-group differences and similar postintervention adaptations; no endpoint-specific test or equivalence is inferred.

Sources and exact versions

Stable finding ID: finding:examine2025:39364857:1
Source document version: pubmed:39364857:abstract:sha256:7a56c70363bf9b01e1ff346460bda44b713f9e39460821a24b6cef194c282b45
Finding revision: finding:examine2025:39364857:1:v2
Finding version: 2
Finding content hash: sha256:6a10c441bd858c17ff9b87c4f4eebc5a0257747201fdd8879be541359878a0f9
Paper version: 3
Paper version content hash: sha256:2bdb127f3ee25c92a6bf1cb57b2a3eaeea3b9dddd26c082f3a18001ee72c7e56
Source content hash: sha256:c02eb924c0ded4a811423052557666500846d5fc5925ccab4f228919d8a868fb
Extraction policy: context164-source-topic-policy:d2c863b8d9f94acf3a7378bfa6e49a23bd72eea4408a689b542d3f7244fd7bfb
Extraction policy hash: sha256:d2c863b8d9f94acf3a7378bfa6e49a23bd72eea4408a689b542d3f7244fd7bfb
Extraction method version: source-reported-records/v1
Field locators: study_comparisons.clause0 → https://eutils.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&id=39364857&rettype=abstract&retmode=text: abstract:624-829; study_comparisons.clause1 → https://eutils.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&id=39364857&rettype=abstract&retmode=text: abstract:830-914; study_comparisons.clause2 → https://eutils.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&id=39364857&rettype=abstract&retmode=text: abstract:915-973; study_comparisons.clause3 → https://eutils.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&id=39364857&rettype=abstract&retmode=text: abstract:1034-1326; study_comparisons.clause4 → https://eutils.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&id=39364857&rettype=abstract&retmode=text: abstract:1327-1451; study_comparisons.clause5 → https://eutils.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&id=39364857&rettype=abstract&retmode=text: abstract:1452-1550; study_comparisons.clause6 → https://eutils.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&id=39364857&rettype=abstract&retmode=text: abstract:1551-1705; study_comparisons.clause7 → https://eutils.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&id=39364857&rettype=abstract&retmode=text: abstract:1706-1866

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&id=39364857&rettype=abstract&retmode=text — document version pubmed:39364857:abstract:sha256:7a56c70363bf9b01e1ff346460bda44b713f9e39460821a24b6cef194c282b45 — sha256:c02eb924c0ded4a811423052557666500846d5fc5925ccab4f228919d8a868fb
- study_comparisons.clause0 → abstract:624-829
- study_comparisons.clause1 → abstract:830-914
- study_comparisons.clause2 → abstract:915-973
- study_comparisons.clause3 → abstract:1034-1326
- study_comparisons.clause4 → abstract:1327-1451
- study_comparisons.clause5 → abstract:1452-1550
- study_comparisons.clause6 → abstract:1551-1705
- study_comparisons.clause7 → abstract:1706-1866
- study_comparisons.clause0 → abstract:624-829
- study_comparisons.clause1 → abstract:830-914
- study_comparisons.clause2 → abstract:915-973
- study_comparisons.clause3 → abstract:1034-1326
- study_comparisons.clause4 → abstract:1327-1451
- study_comparisons.clause5 → abstract:1452-1550
- study_comparisons.clause6 → abstract:1551-1705
- study_comparisons.clause7 → abstract:1706-1866
- sourceTopic.typedRole → Abstract, source context clause 1
- sourceTopic.typedRole → Abstract, source context clause 2
- sourceTopic.typedRole → Abstract, source context clause 3
- sourceTopic.typedRole → Abstract, source context clause 4
- sourceTopic.typedRole → Abstract, source context clause 5
- sourceTopic.typedRole → Abstract, source context clause 6
- sourceTopic.typedRole → Abstract, source context clause 7
- sourceTopic.typedRole → Abstract, source context clause 8
- study_comparisons.clause0 → abstract:624-829
- study_comparisons.clause1 → abstract:830-914
- study_comparisons.clause2 → abstract:915-973
- study_comparisons.clause3 → abstract:1034-1326
- study_comparisons.clause4 → abstract:1327-1451
- study_comparisons.clause5 → abstract:1452-1550
- study_comparisons.clause6 → abstract:1551-1705
- study_comparisons.clause7 → abstract:1706-1866
- sourceTopic.typedRole → Abstract, source context clause 1
- sourceTopic.typedRole → Abstract, source context clause 2
- sourceTopic.typedRole → Abstract, source context clause 3
- sourceTopic.typedRole → Abstract, source context clause 4
- sourceTopic.typedRole → Abstract, source context clause 5
- sourceTopic.typedRole → Abstract, source context clause 6
- sourceTopic.typedRole → Abstract, source context clause 7
- sourceTopic.typedRole → Abstract, source context clause 8
- study_comparisons.clause0 → abstract:624-829
- study_comparisons.clause1 → abstract:830-914
- study_comparisons.clause2 → abstract:915-973
- study_comparisons.clause3 → abstract:1034-1326
- study_comparisons.clause4 → abstract:1327-1451
- study_comparisons.clause5 → abstract:1452-1550
- study_comparisons.clause6 → abstract:1551-1705
- study_comparisons.clause7 → abstract:1706-1866
- sourceTopic.typedRole → Abstract, source context clause 1
- sourceTopic.typedRole → Abstract, source context clause 2
- sourceTopic.typedRole → Abstract, source context clause 3
- sourceTopic.typedRole → Abstract, source context clause 4
- sourceTopic.typedRole → Abstract, source context clause 5
- sourceTopic.typedRole → Abstract, source context clause 6
- sourceTopic.typedRole → Abstract, source context clause 7
- sourceTopic.typedRole → Abstract, source context clause 8
- study_comparisons.clause0 → abstract:624-829
- study_comparisons.clause1 → abstract:830-914
- study_comparisons.clause2 → abstract:915-973
- study_comparisons.clause3 → abstract:1034-1326
- study_comparisons.clause4 → abstract:1327-1451
- study_comparisons.clause5 → abstract:1452-1550
- study_comparisons.clause6 → abstract:1551-1705
- study_comparisons.clause7 → abstract:1706-1866
- sourceTopic.typedRole → Abstract, source context clause 1
- sourceTopic.typedRole → Abstract, source context clause 2
- sourceTopic.typedRole → Abstract, source context clause 3
- sourceTopic.typedRole → Abstract, source context clause 4
- sourceTopic.typedRole → Abstract, source context clause 5
- sourceTopic.typedRole → Abstract, source context clause 6
- sourceTopic.typedRole → Abstract, source context clause 7
- sourceTopic.typedRole → Abstract, source context clause 8

Finding destinations and coverage · 1 records

One finding, several views

Where these findings appear

Versioned source
Admitted finding
Guarded views

A finding keeps the same identity, version and evidence hash across its views. Source status is not human clinical review.

Eligibility is not a live presence check. Contextual links below have a current guarded scope match. A linked page’s filters, safety checks and availability can still prevent it from displaying this finding. A match does not establish an individual benefit.

Multiple source-reported outcomes finding

Finding version 2 · Paper version 3

AI-extracted — pending human review

Direct finding access

This page shows the admitted finding. Other access paths recheck source authority when opened.

Eligible contextual views

Eligible view: Resistance training sequencesRelated-context scope match
Eligible view: Muscle strengthRelated-context scope match
Eligible view: Muscle sizeRelated-context scope match
Eligible view: Jump performanceRelated-context scope match

Private save option

Bring into My Profile

Review the current evidence and explicitly choose whether to save it. This public page does not know whether anyone has saved it. Nothing is saved by opening the link.

Check actual public destinations

Eligibility and displayed coverage are different. This optional check reads the public responses below without signing in. It checks this exact finding version and hash, and rechecks current source authority before and after. Proven nonmatches are not coverage gaps; unavailable scope reads leave applicability unknown. Those destinations are not fetched. It cannot inspect private saves.

No actual-presence claim is made until you run the check.

Canonical study and reading formatsDirect access pathPresence not checked
Research libraryDirect access pathPresence not checked
Paper evidence version 3Direct access pathPresence not checked
Versioned paper JSONDirect access pathPresence not checked
Current findings JSON for this paperDirect access pathPresence not checked
Sleep-quality topicNo admitted scope matchNot applicable: no admitted scope match
Magnesium overviewNo admitted scope matchNot applicable: no admitted scope match
Magnesium belief and evidence viewNo admitted scope matchNot applicable: no admitted scope match
Melatonin overviewNo admitted scope matchNot applicable: no admitted scope match
Melatonin belief and evidence viewNo admitted scope matchNot applicable: no admitted scope match
Sleep outcomeNo admitted scope matchNot applicable: no admitted scope match
Sleep goalNo admitted scope matchNot applicable: no admitted scope match
Magnesium and sleep questionNo admitted scope matchNot applicable: no admitted scope match
Composed magnesium and sleep answerNo admitted scope matchNot applicable: no admitted scope match
Melatonin and sleep questionNo admitted scope matchNot applicable: no admitted scope match
Composed melatonin and sleep answerNo admitted scope matchNot applicable: no admitted scope match
Resistance training sequencesGuarded scope matchPresence not checked
Muscle strengthGuarded scope matchPresence not checked
Muscle sizeGuarded scope matchPresence not checked
Jump performanceGuarded scope matchPresence not checked
Magnesium and melatonin comparisonNo admitted scope matchNot applicable: no admitted scope match

Exact finding and paper identity

Stable finding: finding:examine2025:39364857:1
Finding revision: finding:examine2025:39364857:1:v2
Finding evidence hash: sha256:6a10c441bd858c17ff9b87c4f4eebc5a0257747201fdd8879be541359878a0f9
Paper version hash: sha256:2bdb127f3ee25c92a6bf1cb57b2a3eaeea3b9dddd26c082f3a18001ee72c7e56

Additional extraction and platform record details

These additional records are separate from the source-reported findings above. Platform estimates and grades are not results reported by this paper.

Provisional evidence

Existing platform assessment, not a source-reported finding: the values below are produced by EvidenceBased's own synthesis and certainty engines.

Search coverage: incomplete

Provisional certainty: cannot yet be calculated

Display grade: not assigned

Review status: AI-processed — pending human review

AI-processed extraction

Document integrity: current

Partial extraction: the arms shown may be a subset of the study arms. Read the source for the complete study design.

Arms

Results

Outcome	Estimate	Source anchor

Outcome mapping proposals

Machine-readable paper projection →